OTOLARYNGOLOGY / STATE OF THE ART PAPER
 
KEYWORDS
TOPICS
ABSTRACT
Obstructive sleep apnea (OSA) is the most common type of sleep-related breathing disorder, characterized by repeated episodes of upper airway collapse and resulting hypoxia during sleep. Intermittent hypoxemia may exert a multisystemic impact and modulate the course of comorbidities. Pathophysiological mechanisms such as oxidative stress, inflammation, and endothelial dysfunction contribute to adverse health outcomes including cardiovascular disease, cerebrovascular complications, metabolic disorders, cancer, neurodegenerative conditions, or behavioral abnormalities. Treatment of OSA may mitigate progression of comorbidities and reduce the associated social and economic burden. This literature review aims to explore the relationships between OSA and selected comorbid diseases, including chronic obstructive pulmonary disease (COPD), stroke, diabetes, cancer, and hypertension, based on cohort studies in the literature.
REFERENCES (60)
1.
Bonsignore MR, Lombardi C, Lombardo S, Fanfulla F. Epidemiology, physiology and clinical approach to sleepiness at the wheel in OSA patients: a narrative review. J Clin Med 2022; 11: 3691.
 
2.
Locke BW, Lee JJ, Sundar KM. OSA and chronic respiratory disease: mechanisms and epidemiology. Int J Environ Res Public Health. 2022; 19: 5473.
 
3.
Kuczyński W, Kudrycka A, Małolepsza A, Karwowska U, Białasiewicz P, Białas A. The epidemiology of obstructive sleep apnea in Poland – polysomnography and positive airway pressure therapy. Int J Environ Res Public Health 2021; 18: 2109.
 
4.
Hall KA, Singh MM, Mukherjee S, Palmer LJ. Physical activity is associated with reduced prevalence of self-reported obstructive sleep apnea in a large, general population cohort study. J Clin Sleep Med 2020; 16: 1179-87.
 
5.
Pinilla L, Santamaria-Martos F, Benıtez ID, et al. Association of obstructive sleep apnea with the aging process. Ann Am Thorac Soc 2021; 18: 1540-7.
 
6.
Lopez-Padilla D, Teran-Tinedo J, Cerezo-Lajas A, et al. Moderate obstructive sleep apnea and cardiovascular outcomes in older adults: a propensity score-matched multicenter study (CPAGE-MODE study). J Clin Sleep Med 2022; 18: 553-561.
 
7.
Czerwaty K, Dżaman K, Sobczyk KM, Sikorska KI. The overlap syndrome of obstructive sleep apnea and chronic obstructive pulmonary disease: a systematic review. Biomedicines 2022; 11: 16.
 
8.
He Z, Xue X, Gao Y, et al. Association analysis of frailty with obstructive sleep apnea syndrome in elderly patients – a multicenter cohort study. Res Sq 2023. DOI: 10.21203/RS.3.RS-2828248/V1.
 
9.
Povitz M, Bray Jenkyn K, Kendzerska T, et al. Clinical pathways and wait times for OSA care in Ontario, Canada: a population cohort study. Can J Respir Crit Care Sleep Med 2019; 3: 91-9.
 
10.
Di Pumpo M, Nurchis MC, Moffa A, et al. Multiple-access versus telemedicine home-based sleep apnea testing for obstructive sleep apnea (OSA) diagnosis: a cost-minimization study. Sleep Breath 2022; 26: 1641-7.
 
11.
Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA 2020; 323: 1389-400.
 
12.
Carmona-Pírez J, Poblador-Plou B, Ioakeim-Skoufa I, et al. Multimorbidity clusters in patients with chronic obstructive airway diseases in the EpiChron Cohort. Sci Rep 2021; 11: 4784.
 
13.
Brennan M, McDonnell MJ, Walsh SM, Gargoum F, Rutherford R. Review of the prevalence, pathogenesis and management of OSA-COPD overlap. Sleep Breath 2022; 26: 1551-60.
 
14.
Stepan B, Cservid L, Raduna O, et al. Severity of oxygen desaturation in OSA-COPD overlap syndrome compared to OSA alone: an observational cohort study. Pneumologia 2022; 71: 22-7.
 
15.
Ioachimescu OC, Janocko NJ, Ciavatta MM, Howard M, Warnock MV. Obstructive Lung Disease and Obstructive Sleep Apnea (OLDOSA) cohort study: 10-year assessment. J Clin Sleep Med 2022; 18: 553-61.
 
16.
Mohammad OI, Elgazzar AG, Mahfouz SM, Elnaggar ME. Prevalence of obstructive sleep apnea among patients with chronic obstructive pulmonary disease. Egypt J Bronchol 2021; 15. DOI: 10.1186/s43168-021-00093-8.
 
17.
Peng T, Yuan S, Wang W, et al. A risk-predictive model for obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Front Neurosci 2023; 17: 1146424.
 
18.
Marin JM, Soriano JB, Marin-Oto M, et al. Sleep-disordered breathing in patients with chronic obstructive pulmonary disease: prevalence and outcomes. Ann Am Thorac Soc 2025; 22: 1227-35.
 
19.
Alkhayat K, Hussein MT, Mohammed OA, Mohammadien HA. Prevalence of obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Egypt J Chest Dis Tuberc 2021; 70: 441-6.
 
20.
Kendzerska T, Povitz M, Bai X, Pakhale S, Wen SW, Gershon AS. Coexistence of clinically significant obstructive sleep apnea with physician-diagnosed asthma or chronic obstructive pulmonary disease: A population study of prevalence and mortality. Can J Respi Crit Care Sleep Med 2022; 6: 24-34.
 
21.
Sterling KL, Pépin JL, Linde-Zwirble W, et al. Impact of positive airway pressure therapy adherence on outcomes in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2022; 206: 197-205.
 
22.
Haula TM, Puustinen J, Takala M, Holm A. Wake-up strokes are linked to obstructive sleep apnea and worse early functional outcome. Brain Behav 2021; 11: e2284.
 
23.
Khot SP, Lisabeth LD, Kwicklis M, et al. Heterogeneity of obstructive sleep apnea phenotypes after ischemic stroke: outcome variation by cluster analysis. Sleep Med 2024; 114: 145-50.
 
24.
Wang B, Hao W, Fan J, et al. Clinical significance of obstructive sleep apnea in patients with acute coronary syndrome with or without prior stroke: a prospective cohort study. Eur J Med Res 2023; 28: 107.
 
25.
Lin HJ, Chen PC, Liu YH, Hsu CY. Increasing and high prevalence of moderate to severe obstructive sleep apnea in acute ischemic stroke in Taiwan. J Formos Med Assoc 2024; 123: 408-14.
 
26.
Edrissi C, Rathfoot C, Knisely K, Sanders CB, Poupore N, Nathaniel T. Gender disparity in a cohort of stroke patients with incidence of obstructive sleep apnea. J Vasc Nurs 2022; 40: 17-27.
 
27.
Haula TM, Puustinen J, Takala M, Holm A. Relationship between SDB and short-term outcome in Finnish ischemic stroke patients. Brain Behav 2020; 10: e01762.
 
28.
Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 2021; 52: e364-e467.
 
29.
Andreozzi F, Van Overstraeten C, Ben Youssef S, et al. African ethnicity is associated with a higher prevalence of diabetes in obstructive sleep apnea patients: results of a retrospective analysis. Sleep Breath 2020; 24: 857-64.
 
30.
Vacelet L, Hupin D, Pichot V, et al. Insulin resistance and type 2 diabetes in asymptomatic obstructive sleep apnea: results of the PROOF cohort study after 7 years of follow-up. Front Physiol 2021; 12: 650758.
 
31.
Bruyneel M, Kleynen P, Poppe K. Prevalence of undiagnosed glucose intolerance and type 2 diabetes in patients with moderate-to-severe obstructive sleep apnea syndrome. Sleep Breath 2020; 24: 1389-95.
 
32.
Zhang Q, Zhang Q, Li X, et al. Association of obstructive sleep apnea symptoms with all-cause mortality and cause-specific mortality in adults with or without diabetes: a cohort study based on the NHANES. J Diabetes 2024; 16: e13538.
 
33.
Su X, Li JH, Gao Y, et al. Impact of obstructive sleep apnea complicated with type 2 diabetes on long-term cardiovascular risks and all-cause mortality in elderly patients. BMC Geriatr 2021; 21: 508.
 
34.
Adderley NJ, Subramanian A, Toulis K, et al. Obstructive sleep apnea, a risk factor for cardiovascular and microvascular disease in patients with type 2 diabetes: findings from a population-based cohort study. Diabetes Care 2020; 43: 1868-77.
 
35.
Ding Q, Qin L, Wojeck B, et al. Polysomnographic phenotypes of obstructive sleep apnea and incident type 2 diabetes results from the dream study. Ann Am Thorac Soc 2021; 18: 2067-78.
 
36.
Shi H, Xiang S, Huang X, Wang L, Hua F, Jiang X. Development and validation of a nomogram for predicting the risk of obstructive sleep apnea in patients with type 2 diabetes. Ann Transl Med 2020; 8: 1675.
 
37.
Wojeck BS, Inzucchi SE, Qin L, Yaggi HK. Polysomnographic predictors of incident diabetes and pre-diabetes: an analysis of the DREAM study. J Clin Sleep Med 2023; 19: 703-10.
 
38.
Labarca G, Dreyse J, Salas C, et al. Risk of mortality among patients with moderate to severe obstructive sleep apnea and diabetes mellitus: results from the SantOSA cohort. Sleep Breath 2021; 25: 1467-75.
 
39.
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024; 74: 12-49.
 
40.
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-263.
 
41.
Dizon DS, Kamal AH. Cancer statistics 2024: all hands on deck. CA Cancer J Clin 2024; 74: 8-9.
 
42.
Chen CY, Hu JM, Shen CJ, et al. Increased incidence of colorectal cancer with obstructive sleep apnea: a nationwide population-based cohort study. Sleep Med 2020; 66: 15-20.
 
43.
Marriott RJ, Singh B, McArdle N, et al. Does OSA increase risk for cancer?: A Large Historical Sleep Clinic Cohort Study. Chest 2023; 164: 1042-56.
 
44.
Xiong H, Lao M, Wang L, et al. The incidence of cancer is increased in hospitalized adult patients with obstructive sleep apnea in China: a retrospective cohort study. Front Oncol 2022; 12: 856121.
 
45.
Kendzerska T, Povitz M, Leung RS, et al. Obstructive sleep apnea and incident cancer: A large retrospective multicenter clinical cohort study. Cancer Epidemiol Biomarkers Prev 2021; 30: 295-304.
 
46.
Justeau G, Gervès-Pinquié C, Le Vaillant M, et al. Association between nocturnal hypoxemia and cancer incidence in patients investigated for OSA: data from a large multicenter French cohort. Chest 2020; 158: 2610-20.
 
47.
Kendzerska T, Gershon AS, Povitz M, et al. Polysomnographic markers of obstructive sleep apnea severity and cancer-related mortality a large retrospective multicenter clinical cohort study. Ann Am Thorac Soc 2022; 19: 807-18.
 
48.
Theorell-Haglöw J, Zhou X, Wittert G, et al. Does obstructive sleep apnea increase the risk of cancer and cancer mortality in combined community-based cohorts? J Sleep Res 2024; 33: e14089.
 
49.
Cho J, Jo S. Association of obstructive sleep apnea with risk of lung cancer: a nationwide cohort study in Korea. Sci Rep 2024; 14: 12394.
 
50.
Justeau G, Bailly S, Gervès-Pinquié C, et al. Cancer risk in patients with sleep apnoea following adherent 5-year CPAP therapy. Eur Respir J 2022; 59: 2101935.
 
51.
Kendzerska T, Murray BJ, Gershon AS, et al. Polysomnographic assessment of sleep disturbances in cancer development: a historical multicenter clinical cohort study. Chest 2023; 164: 517-30.
 
52.
Falla C, Young A, Pope A, O’Driscoll DM. Obstructive sleep apnea during REM sleep: effects on morning and evening blood pressure. Sleep 2023; 46: zsac259.
 
53.
Yao L, Heizhati M, Lin M, et al. Elevated body mass index increases the risk of cardiovascular events in hypertensive patients accompanied with obstructive sleep apnea: a cohort study. Obes Res Clin Pract 2022; 16: 491-9.
 
54.
Zhao LB, Gao YH, Xu WH, Li KL, Liu L, Fan L. Factors influencing new-onset hypertension in elderly patients with obstructive sleep apnea: a multicenter cohort study. Clin Transl Sci 2023; 16: 2507-18.
 
55.
Lin YC, Chen CT, Chao PZ, et al. Prevention of incident hypertension in patients with obstructive sleep apnea treated with uvulopalatopharyngoplasty or continuous positive airway pressure: a cohort study. Front Surg 2022; 9: 818591.
 
56.
Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 2023; 41: 1874-2071.
 
57.
Cai X, Hu J, Wen W, et al. Associations of the cardiometabolic index with the risk of cardiovascular disease in patients with hypertension and obstructive sleep apnea: results of a longitudinal cohort study. Oxid Med Cell Longev 2022; 2022: 4914791.
 
58.
Park S, Shin B, Lee JH, et al. Polysomnographic phenotype as a risk factor for cardiovascular diseases in patients with obstructive sleep apnea syndrome: a retrospective cohort study. J Thorac Dis 2020; 12: 907-15.
 
59.
Zota IM, Roca M, Leon MM, et al. Long-term adherence in overweight patients with obstructive sleep apnea and hypertension – a pilot prospective cohort study. Diagnostics 2023; 13: 1447.
 
60.
Wang X, Guan L, Wu C, Zhao Y, Zhao G. Continuous positive airway pressure may improve hypertension in patients with obstructive sleep apnea-hypopnea syndrome by inhibiting inflammation and oxidative stress. Arch Med Sci 2023; 19: 237-41.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top